Member of the Board of Directors
Orchard Therapeutics is a biotechnology company incorporated in September 2015 and dedicated to bringing transformative gene therapies to patients with serious and life-threatening orphan diseases
Life sciences executive with proven experience leading biotech, medical device and pharmaceutical companies through development and commercialization. Successfully financed several venture-backed and public companies raising more than $2.0 billion in equity and debt capital. Adept at using investor capital efficiently, identifying optimal commercialization strategies, and establishing strategic partnerships to gain optimal liquidity events for investors. Clear and effective communicator with the demonstrated ability to set milestones and motivate an organization to achieve them.Specialties: Strategic planning and operational execution; IPO, public and private financing strategies; life science product and portfolio management and prioritization; business and corporate development, including co-develop, co-promotion and $1.3 billion M&A transactions; public company Board of Director experience, extensive relationships with buy side and sell side investors, adept at investor and strategic communication strategies.